Larvol Delta - Cellenkos-Presents-Phase-1b-Data-at-ASH-2024-Showcasing-the-Potential-of-TRegulatory-Cell-Therapy-Candidate-CK0804-for-Myelobrosis

CK0804 - Cellenkos, Incyte

https://www.globenewswire.com/news-release/2024/12/10/2994370/0/en/Cellenkos-Presents-Phase-1b-Data-at-ASH-2024-Showcasing-the-Potential-of-T-Regulatory-Cell-Therapy-Candidate-CK0804-for-Myelofibrosis.html

Dec 10, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next